2024
Aurelius Therapeutics incorporated as a spin-off of Radboudumc and Radboud University
Aurelius Therapeutics B.V. was incorporated in Nijmegen in 2024 as a spin-off of Radboudumc and Radboud University, to develop radioligand therapies that combine selective tumor-targeting molecules with therapeutic radioisotopes, for solid tumors with few treatment options. Radboudumc spin-off profile